Skip to main content
. 2020 Sep 10;8(3):517. doi: 10.3390/vaccines8030517

Table 1.

Biological effects of LL-37 in psoriasis and lupus erythematosus.

LL-37-Mediated Pathogenic Events Psoriasis Lupus Erythematosus
LL-37 induces the release of inflammatory mediators by keratinocytes
LL-37 induces keratinocyte migration and proliferation
+
+
+
 
LL-37 reduces keratinocytes apoptosis +
LL-37/DNA complexes as autoantigens + +
LL-37/DNA complexes stimulate pDCs to high IFN-α production + +
LL-37/RNA complexes stimulate mDCs to high TNF-α and IL-6 +
Presence of LL-37-specific, IFN-γ positive CD4+ and CD8+ T cells +
LL-37-specific T cells promote anti-LL-37 antibody production by B cells +